FDA requires warning on GLP-1 drugs over potential risk of rare eye condition

NAION is characterised by a sudden decrease in vision that can lead to permanent sight loss. It occurs when blood flow to the front part of the optic nerve is reduced, although the exact cause of the reduced blood flow is not fully understood.